首页> 外文OA文献 >The Relative Efficacy and Safety of Mirabegron and OnabotulinumtoxinA in Patients With Overactive Bladder who Have Previously Been Managed With an Antimuscarinic: A Network Meta-analysis

【2h】

The Relative Efficacy and Safety of Mirabegron and OnabotulinumtoxinA in Patients With Overactive Bladder who Have Previously Been Managed With an Antimuscarinic: A Network Meta-analysis

机译：Mirabegron和OnaboTulinumtoxina患者以前用抗血清素治疗的过度活性膀胱患者的相对疗效和安全性：网络元分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Greta Lozano-Ortega; David Walker; Basia Rogula; Alison Deighton; Karissa Johnston; Neil Hawkins; Roger Dmochowski;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The Relative Efficacy and Safety of Mirabegron and OnabotulinumtoxinA in Patients With Overactive Bladder who Have Previously Been Managed With an Antimuscarinic: A Network Meta-analysis [J] . Lozano-Ortega Greta, Walker David, Rogula Basia, Urology . 2019,第期

机译：Mirabegron和OnaboTulinumtoxina患者以前用抗血清素治疗的过度活性膀胱患者的相对疗效和安全性：网络元分析
2. Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo [J] . Chapple Christopher R., Cruz Francisco, Cardozo Linda, European urology . 2020,第1期

机译：M拉释的安全性和疗效：对接受M拉释，抗血清或安慰剂的过度活性膀胱患者大型综合临床试验数据库的分析
3. The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial [J] . Jose E. Batista, Heinz K?lbl, Sender Herschorn, Therapeutic advances in urology. . 2015,第4期

机译：米拉贝隆与索非那新相比因缺乏疗效而对先前过度抗毒蕈碱治疗不满意的膀胱过度活跃患者的疗效和安全性：一项非劣效性，随机，IIIb期临床试验的结果
4. Electrical Stimulation of the Transcutaneous Posterior Tibial Nerve for the Treatment of Patients with Detrusor Overactivity Due to Neurogenic Hiperactive Bladder in Multiple Sclerosis A Case Study [C] . Fabiana S. B. Perez, Luciana R. Tenorio Peixoto, Fabiano Soares, International Conference on Biomedical Electronics and Devices . 2014

机译：经皮后胫骨神经的电气刺激治疗多发性硬化中神经源性膀胱患者患者的患者案例研究
5. Understanding treatment-related symptoms, symptom management techniques, and symptom management self-efficacy in a sample of non-muscle invasive bladder cancer patients [D] . Hinojosa-Lindsey, Marilyn 2010

机译：了解非肌肉浸润性膀胱癌患者样本中与治疗相关的症状，症状管理技术和症状管理自我效能
6. Editorial commentary on Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron Antimuscarinics or Placebo [O] . Tomonori Yamanishi, Tomohiko Kamasasko, Kanya Kaga, 2020

机译：关于 Mirabegron的安全性和有效性：接受Mirabegron抗毒蕈碱药物或安慰剂治疗的膀胱过度活动症患者的大型综合临床试验数据库的分析的社论评论
7. The Efficacy and Safety of Mirabegron Relative to Onabotulinumtoxina in Patients with Overactive Bladder Not Appropriately Managed with An Antimuscarinic: A Network Meta-Analysis [O] . G Lozano-Ortega, K Gooch, D Walker, 2018

机译：M拉萨比焦顿相对于甲豆内霉素的疗效和安全性与抗血清胰岛素的过度活性膀胱患者患者：网络元分析
8. Double Blind, Randomized Study of Safety and Efficacy of OnabotulinumtoxinA (OnaBoNT A) versus Oral Oxybutynin in SCI Patients with NDO (11 09 10 04). [R] . Smith, C. P. 2017

机译：双盲，随机研究Onabotulinumtoxina（OnaBoNT a）与口服奥昔布宁在NDO患者中的安全性和有效性（11 09 10 04）。

The Relative Efficacy and Safety of Mirabegron and OnabotulinumtoxinA in Patients With Overactive Bladder who Have Previously Been Managed With an Antimuscarinic: A Network Meta-analysis

著录项

相似文献

相关主题

期刊订阅